Clinical Trials Directory

Trials / Completed

CompletedNCT03801837

Effect of Macadamia Nut on Cardiometabolic Risk Factors

Macadamia Nut Effects on Adiposity and Cardiometabolic Risk Factors

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
38 (actual)
Sponsor
Loma Linda University · Academic / Other
Sex
All
Age
40 Years – 75 Years
Healthy volunteers
Accepted

Summary

This research study will test the effects of macadamia nuts on adiposity, and traditional and emergent risk factors of cardiometabolic disease in adult men and women

Detailed description

Purpose of this study is to investigate the effects of Macadamia nuts on body weight, adiposity, , oxidative stress, glucose, insulin an lipid levels. it will a randomized cross over study that will include two study diets (Macadamia nut diet and control diet) with a wash out period of 4 weeks in between. 40 subjects will be selected and randomized into either of the two phases. During the Macadamia nut diet phase subjects will be provided the appropriate portion of Macadamia nuts (15% of daily calories or 30-45 grams based on kcal requirement of the individual, instructions will be provided on how to incorporate nuts into the diet. this phase will last for 8 weeks. During the control diet phase, subjects will continue with their normal diet and abstain from eating nuts. subjects will be tested for various outcomes at baseline and twice at the end of each phase. The intervention will last for 5 months in total.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMacadamia NutParticipants will be provided with the appropriate portion of macadamia nuts \[15% of daily calories or 30-45 grams based on kcal requirement of the individual\]
DIETARY_SUPPLEMENTControl DietParticipants will continue with their Habitual Diet during this part of the intervention

Timeline

Start date
2019-06-24
Primary completion
2019-11-25
Completion
2019-11-25
First posted
2019-01-14
Last updated
2023-03-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03801837. Inclusion in this directory is not an endorsement.